Real-world data show DoxyPEP implementation among PrEP users significantly reduces the incidence of chlamydia and syphilis.

Among individuals using HIV pre-exposure prophylaxis (HIV PrEP), doxycycline post-exposure prophylaxis (doxyPEP) was associated with a substantial decline in chlamydia and syphilis incidence.

Please provide your email address to receive an email when new articles are posted on . The CDC’s recent clinical guidelines recommend discussing doxy-PEP for STI prevention with certain populations.

Doxycycline postexposure prophylaxis (doxyPEP) has the potential to substantially reduce real-world population-level incidence of sexually transmitted infections (STIs), a study in JAMA Internal ...

A new study in JAMA Internal Medicine led by the Harvard Pilgrim Health Care Institute examined whether doxycycline post-exposure prophylaxis (doxyPEP) was associated with declines in bacterial ...

The CDC finalized new guidelines that recommend doxycycline post-exposure prophylaxis (doxy PEP) for at-risk gay, bisexual, and other men who have sex with men (MSM) and transgender women (TGW) to ...

Doxycycline, an antibiotic widely used to combat acne, malaria and Lyme disease, has been recommended by the CDC for use in the United States by gay and bisexual men and transgender women after having ...

After years of rising rates of syphilis and chlamydia among queer men, it appears a new tool is helping to curb infections. A study says that taking DoxyPEP reduced the incidence of chlamydia and ...